LENALIDOMIDE in Slovenian translation

• lenalidomid
• skupino z lenalidomidom

Examples of using Lenalidomide in English and their translations into Slovenian

including both lenalidomide and bortezomib, and whose disease progressed after the last treatment.
vključno z lenalidomidom in bortezomibom, in pri katerih je bolezen po zadnjem zdravljenju napredovala.

In mantle cell lymphoma patients, lenalidomide is associated with a higher incidence of grade 3
Pri bolnikih z limfomom plaščnih celic je lenalidomid povezan z večjo incidenco nevtropenije 3. ali 4. stopnje(43,7% pri bolnikih,

In myelodysplastic syndromes patients, lenalidomide is associated with a higher incidence of grade 3
Pri bolnikih z mielodisplastičnimi sindromi je lenalidomid povezan s povečano incidenco nevtropenije ali 4. stopnje(74,6% pri bolnikih,

All treatment-emergent adverse events with≥ 5% of subjects in lenalidomide arm and at least 2% difference in proportion between lenalidomide and control arm.
Vsi neželeni dogodki, ki so se pojavili v zvezi z zdravljenjem z zdravilom pri ≥ 5% preskušancev v skupini z lenalidomidom in vsaj 2% razlika v deležu med skupino z lenalidomidom in kontrolno skupino.

older who received lenalidomide, there was a higher incidence of serious adverse reactions
so prejemali lenalidomid, je bila večja incidenca resnih neželenih učinkov

at least 1.0% difference in proportion between lenalidomide and control arm.
skupini z lenalidomidom in vsaj 1,0% razlika v deležu med skupino z lenalidomidom in kontrolno skupino..

in which 148 patients received lenalidomide at a dose of 10 mg,
v kateri je 148 bolnikov prejemalo lenalidomid v odmerku 10 mg,

KRd= Kyprolis, lenalidomide and dexamethasone; Rd= lenalidomide, dexamethasone; PFS= progression-free survival;
KRd= Kyprolis, lenalidomid in deksametazon, Rd= lenalidomid in deksametazon, PFS= preživetje brez napredovanja,

Lenalidomide is present in human semen(<
Lenalidomid je prisoten v humani spermi(<

should be used with caution in multiple myeloma patients receiving lenalidomide with dexamethasone(see sections 4.4 and 4.8).
je hormonsko nadomestno zdravljenje, je treba pri bolnikih z multiplim mielomom, ki prejemajo lenalidomid v kombinaciji z deksametazonom, uporabljati previdno(glejte poglavji 4. 4 in 4. 8).

early deaths in the lenalidomide arm and 2/28(7%)
v skupini z lenalidomidom je bilo 16/81(20%)

Results from human in vitro metabolism studies indicate that lenalidomide is not metabolised by cytochrome P450 enzymes suggesting that administration of lenalidomide with drugs that inhibit cytochrome P450 enzymes is not likely to result in metabolic drug interactions in man.
Rezultati študij presnove pri človeku in vitro kažejo, da lenalidomida ne presnavljajo encimi citokroma P450, kar kaže, da ni verjetno, da bi uporaba lenalidomida z zdravili, ki zavirajo encime citokroma P450, pri človeku povzročila presnovne interakcije med zdravili.

Digoxin Concomitant administration with lenalidomide 10 mg/day increased the plasma exposure of digoxin(0.5 mg,
Digoksin Sočasna uporaba z 10 mg/ dan lenalidomida je povečala izpostavljenost digoksina v plazmi(0,

Results from human in vitro metabolism studies indicate that lenalidomide is not metabolised by cytochrome P450 enzymes suggesting that administration of lenalidomide with medicinal products that inhibit cytochrome P450 enzymes is not likely to result in metabolic medicinal product interactions in humans.
Rezultati študij presnove pri človeku in vitro kažejo, da lenalidomida ne presnavljajo encimi citokroma P450, kar kaže, da ni verjetno, da bi uporaba lenalidomida z zdravili, ki zavirajo encime citokroma P450, pri človeku povzročila presnovne interakcije med zdravili.

Return to≥ 0.5 x 109/L Resume lenalidomide at next lower dose level once daily. ªIf the subject has not been receiving G-CSF therapy,
Vrne na ≥ 0,5 x 109/l nadaljujte zdravljenje z lenalidomidom na naslednji nižji ravni odmerka enkrat na dan. ªČe bolnik ni prejemal zdravljenja z G-CSF,

Second Primary Malignancies are known to be associated with lenalidomide exposure which was extended in patients treated with Empliciti combined with lenalidomide
Za sekundarne primarne novotvorbe je znano, da so povezane z izpostavljenostjo lenalidomidu, ki pa je bila pri bolnikih, ki so se zdravili z zdravilom Empliciti v kombinaciji z lenalidomidom

SPMs are known to be associated with lenalidomide exposure, which was extended in patients treated with Empliciti combined with lenalidomide
Za SPN je znano, da so povezane z izpostavljenostjo lenalidomidu, ki pa je bila pri bolnikih, ki so se zdravili z zdravilom Empliciti v kombinaciji z lenalidomidom

In the Phase III study, 69 patients were on lenalidomide 5 mg, 69 patients on lenalidomide 10 mg
V študiji faze III je 69 bolnikov prejemalo lenalidomid 5 mg, 69 bolnikov lenalidomid 10 mg in 67 bolnikov placebo

Cases of viral reactivation have been reported in patients receiving lenalidomide, including serious cases of herpes zoster or hepatitis B virus(HBV) reactivation.
Pri bolnikih, ki so prejemali talidomid, so poročali o primerih reaktivacije virusov, vključno z resnimi primeri reaktivacije virusa herpes zoster ali virusa hepatitisa B(HBV- hepatitis B virus).

As Kyprolis is given in combination with lenalidomide, you must follow the Pregnancy Prevention Programme(see package leaflet for lenalidomide for information on pregnancy prevention
Zdravilo Kyprolis se uporablja v kombinaciji z lenalidomidom, zato morate ravnati v skladu s programom za preprečevanje nosečnosti(glejte navodilo za uporabo lenalidomida za informacije o preprečevanju nosečnosti